Respiratory outcomes, utilization and costs 12 months following a respiratory syncytial virus diagnosis among commercially insured late-preterm infants

Current Medical Research and Opinion

Volumn 27, Issue 2, 2011, Pages 403-412

  Palmer, Liisa ^a   Hall, Caroline B ^b   Katkin, Julie P ^c   Shi, Nianwen ^d   Masaquel, Anthony S ^e   McLaurin, Kimmie K ^e   Mahadevia, Parthiv J ^e  

^a THOMSON REUTERS   (United Kingdom)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

^d THOMSON REUTERS   (United States)

^e MEDIMMUNE   (United States)

Author keywords

Costs and cost analysis; Respiratory syncytial virus infection; Utilization; Wheezing

Indexed keywords

ARTICLE; ASTHMA; HEALTH CARE COST; HEALTH CARE UTILIZATION; OUTCOMES RESEARCH; PREMATURITY; PRIVATE HEALTH INSURANCE; RESPIRATORY SYNCYTIAL VIRUS INFECTION;

ALGORITHMS; COHORT STUDIES; COMMERCE; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HEALTH RESOURCES; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INSURANCE COVERAGE; INTENSIVE CARE UNITS, NEONATAL; MALE; RESPIRATION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 78651380660     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.542744     Document Type: Article

References (31)

1. Shay DK, Holman RC, Newman RD, et al. Bronchiolitis-associated hospitali-zations among US children, 1980-1996. JAMA 1999;282:1440-6
2. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003;143:S127-32
3. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009;360:588-98
4. Hall C. Respiratory syncytial virus. In: Feigin R, Cherry J, eds. Textbook of Pediatric Infectious Diseases. Philadelphia: WB Saunders 1998:2087
5. Boyce TG, Mellen BG, Mitchel EF, Jr., et al. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J Pediatr 2000;137:865-70
6. Makari D, Hoopes JM, White N. Impact of RSV: implications for managed care. Managed Care 2009;18:2-7
7. Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2006. National Vital Statistics Reports 2007;56:1-18
8. Martin JA, Kirmeyer S, Osterman M, et al. Born a bit too early: recent trends in late preterm births. NCHS Data Brief 2009;1-8
9. McLaurin KK, Hall CB, Jackson EA, et al. Persistence of morbidity and cost differences between late-preterm and term infants during the first year of life. Pediatrics 2009;123:653-9
10. Stewart DL, Romero JR, Buysman EK, et al. Total healthcare costs in the US for preterm infants with respiratory syncytial virus lower respiratory infection in the first year of life requiring medical attention. Curr Med Res Opin 2009;25:2795-804
11. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999;354: 541-5
12. Broughton S, Roberts A, Fox G, et al. Prospective study of healthcare utilisation and respiratory morbidity due to RSV infection in prematurely born infants. Thorax 2005;60:1039-44
13. Greenough A, Alexander J, Burgess S, et al. Health care utilisation of prematurely born, preschool children related to hospitalisation for RSV infection. Arch Dis Child 2004;89:673-8
14. Sampalis JS. Morbidity and mortality after RSV-associated hospitalizations among premature Canadian infants. J Pediatr 2003;143:S150-6
15. Palmer L, Hall CB, Katkin J, et al. Healthcare costs within a year of respiratory syncytial virus among medicaid infants. Pediatr Pulmonol 2010;45: 772-81.
16. Aujard Y, Fauroux B. Risk factors for severe respiratory syncytial virus infection in infants. Respir Med 2002;96 Suppl B:S9-14
17. Simoes EA. RSV disease in the pediatric population: epidemiology, seasonal variability, and long-term outcomes. Manag Care 2008;17:3-6, discussion 18-9
18. Davis H, Moore Jr RM, Gergen PJ. Cost of hospitalizations associated with sickle cell disease in the United States. Public Health Rep 1997;112:40-3
19. McConnochie K, Roghmann K. Management of the acute episode. Paediatr Respir Rev 1984;1:40-3
20. Imbens G. The role of the propensity score in estimating dose-response functions. Biometrika 2000;87:706-10
21. Imbens G. Nonparametric estimation of average treatment effects under exogeneity: a review. Rev Econ Stat 2004;86:4-29
22. Imai K, Van Dyk D. Causal inference with general treatment regimes: generalizing the propensity score. J Am Stat Assoc 2004;99:854-66
23. McCormick J, Tubman R. Readmission with respiratory syncytial virus (RSV) infection among graduates from a neonatal intensive care unit. Pediatr Pulmonol 2002;34:262-6
24. Henderson J, Hilliard TN, Sherriff A, et al. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study. Pediatr Allergy Immunol 2005;16:386-92
25. Long CE, McBride JT, Hall CB. Sequelae of respiratory syncytial virus infections. A role for intervention studies. Am J Respir Crit Care Med 1995;151:1678-80;discussion 80-1
26. Stensballe LG, Simonsen JB, Thomsen SF, et al. The causal direction in the association between respiratory syncytial virus hospitalization and asthma. J Allergy Clin Immunol 2009;123:131-7 e1
27. Thomsen SF, van der Sluis S, Stensballe LG, et al. Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study. Am J Respir Crit Care Med 2009;179:1091-7
28. Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1995;126:212-19
29. Lanari M, Giovannini M, Giuffre L, et al. Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity. Pediatr Pulmonol 2002;33:458-65
30. Holberg CJ, Wright AL, Martinez FD, et al. Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life. Am J Epidemiol 1991;133:1135-51
31. Colin AA, McEvoy C, Castile RG. Respiratory morbidity and lung function in preterm infants of 32 to 36 weeks' gestational age. Pediatrics 2010;126: 115-28